Resultados da busca - Pere Barba

Refinar Resultados
  1. 1
    Checkpoint inhibitors in AML: are we there yet?

    Checkpoint inhibitors in AML: are we there yet? por Arnab Ghosh, Pere Barba, Miguel‐Angel Perales

    Publicado em 2019
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect

    Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect por Guillermo Ortí, Pere Barba, María Laura Fox, Olga Salamero, Francesc Bosch, David Valcárcel

    Publicado em 2016
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    Invasive Aspergillosis Complicating Pandemic Influenza A (H1N1) Infection in Severely Immunocompromised Patients

    Invasive Aspergillosis Complicating Pandemic Influenza A (H1N1) Infection in Severely Immunocompromised Patients por Carolina García‐Vidal, Pere Barba, Montserrat Arnán, Asunción Moreno, Isabel Ruiz‐Camps, Carlota Gudiol, Josefina Ayats, Guillermo Ortí, Jordi Carratalà

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI Is the Best Predictor of NRM and OS in a Population of Patients Undergoing allo-RIC

    Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI I... por Pere Barba, José Luís Piñana, Rodrigo Martino, David Valcárcel, Alex Amorós, Anna Sureda, Javier Briones, Julio Delgado, Salut Brunet, Jorge Sierra

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease

    Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease por Irene García‐Cadenas, I Rivera, Rodrigo Martino, Albert Esquirol, Pere Barba, Silvana Novelli, Guillermo Ortí, Javier Briones, Salut Brunet, David Valcárcel, Jorge Sierra

    Publicado em 2016
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Early and Long-Term Impaired T Lymphocyte Immune Reconstitution after Cord Blood Transplantation with Antithymocyte Globulin

    Early and Long-Term Impaired T Lymphocyte Immune Reconstitution after Cord Blood Transplantation with Antithymocyte Globulin por Nerea Castillo, Irene García‐Cadenas, Pere Barba, Carme Saurina, Cristina Díaz de Heredia, Rodrigo Martino, Christelle Ferrà, Isabel Badell, Izaskun Elorza, Jorge Sierra, David Valcárcel, Sergio Querol

    Publicado em 2016
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

    Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies por Juan León-Román, Gloria Iacoboni, Sheila Bermejo, Cecilia Carpio, Mónica Bolufer, Clara García-Carro, Mario Sánchez-Salinas, Carla Alonso-Martínez, Oriol Bestard, Pere Barba, María José Soler

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy

    Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy por Ester Márquez‐Algaba, Gloria Iacoboni, Berta Pernas, Juliana Esperalba, Ibai Los‐Arcos, Vı́ctor Navarro, Arnau Monforte, F Beas, Adaia Albasanz‐Puig, Cecilia Carpio, Pere Barba, Isabel Ruiz‐Camps

    Publicado em 2022
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Torque Teno Virus Plasma DNA Load: A Novel Prognostic Biomarker in CAR-T Therapy

    Torque Teno Virus Plasma DNA Load: A Novel Prognostic Biomarker in CAR-T Therapy por Ana Benzaquén, Estela Giménez, Gloria Iacoboni, Manuel Guerreiro, Rafael Hernani, Eliseo Albert, Cecilia Carpio, Aitana Balaguer‐Roselló, Ariadna Pérez, Carlos Solano de la Asunción, Mario Sánchez-Salinas, Pedro Chorão, José Luís Piñana, F Beas, Juan Montoro, Juan Carlos Hernández‐Boluda, Ana Facal, Blanca Ferrer Lores, Marta Villalba, Paula Amat, María Dolores Gómez, Diana Campos, María José Terol, Jaime Sanz, Pere Barba, David Navarro, Carlos Solano, Pere Barba

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Pré-impressão
    Salvar na lista
    Na minha lista:
  10. 10
    Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation

    Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Ris... por Pere Barba, Rodrigo Martino, José Antonio Pérez‐Simón, Francesc Fernández‐Avilés, Nerea Castillo, José Luís Piñana, Lucía López‐Anglada, Montserrat Rovira, Francesc Bosch, Enric Carreras, Lucía López‐Corral, Jorge Sierra, David Valcárcel

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study

    Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH stud... por Mariana Bastos‐Oreiro, Gloria Iacoboni, Vı́ctor Navarro, A Caballero, Núria Martínez, Javier Delgado, Aitana Balaguer‐Roselló, Mi Kwon, Sonia González de Villambrosía, Rafael Hernani, Ana Jiménez Ubieto, Rebeca Bailén, Izaskun Zaberio, Alejandro Martı́n, Pere Barba

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

    Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy por Kai Rejeski, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt‐Baildon, Emmanuel Bachy, Pere Barba, Marion Subklewe

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality

    Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality por Kai Rejeski, Yucai Wang, Doris K. Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Bethge, Javier Muñoz, Razan Mohty, Veit Bücklein, Pere Barba, Frederick L. Locke, Yi Lin, Michael D. Jain, Marion Subklewe

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis

    The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera my... por Juan Carlos Hernández‐Boluda, Arturo Pereira, M. Gómez, Concepción Boqué, Francisca Ferrer‐Marín, J. M. Raya, Valentín García‐Gutiérrez, Ana Kerguelen, Blanca Xicoy, Pere Barba, Jesús Martı́nez, Elisa Luño, Alberto Álvarez‐Larrán, Joaquín Martínez‐López, Elisa Arbelo, Carlos Besses

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Carta
    Salvar na lista
    Na minha lista:
  15. 15
    Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma

    Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma por Gloria Iacoboni, Guillermo Villacampa, Núria Martínez‐Cibrián, Rebeca Bailén, Lucía López‐Corral, Jose M. Sánchez, Manuel Guerreiro, A Caballero, Alberto Mussetti, Juan‐Manuel Sancho, Rafael Hernani, Pau Abrisqueta, Carlos Solano, Anna Sureda, Javier Briones, Alejandro Martı́n, Mi Kwon, Juan Luis Reguera, Pere Barba

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    The <scp>CAR‐HEMATOTOX</scp> score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory <scp>MCL</scp>

    The <scp>CAR‐HEMATOTOX</scp> score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autol... por Kai Rejeski, Yucai Wang, Omar Albanyan, Javier Muñoz, Pierre Sesques, Gloria Iacoboni, Lucía López‐Corral, Isabelle Ries, Veit Bücklein, Razan Mohty, Martin Dreyling, Aliyah Baluch, Bijal Shah, Frederick L. Locke, Georg Heß, Pere Barba, Emmanuel Bachy, Yi Lin, Marion Subklewe, Michael D. Jain

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

    The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL por Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni, Olaf Penack, Veit Bücklein, Liv Jentzsch, Dimitrios Mougiakakos, Grace Johnson, Brian Arciola, Cecilia Carpio, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Frederick L. Locke, Michael von Bergwelt‐Baildon, Andréas Mackensen, Wolfgang Bethge, Pere Barba, Michael D. Jain, Marion Subklewe

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle

    Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle por Benno Lickefett, Lulu Chu, Valentin Ortiz-Maldonado, Linda Warmuth, Pere Barba, Matteo Doglio, David Henderson, Michael Hudecek, Andreas Kremer, Janet L. Markman, Magdalena Nauerth, Hélène Negre, Carmen Sanges, Philipp B. Staber, Rebecca Tanzi, Julio Delgado, Dirk H. Busch, Jürgen Kuball, Maik Luu, Ulrich Jäger

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Prognostic significance of copy number alterations in adolescent and adult patients with precursor <scp>B</scp> acute lymphoblastic leukemia enrolled in <scp>PETHEMA</scp> protocols

    Prognostic significance of copy number alterations in adolescent and adult patients with precursor <scp>B</scp> acute lymphoblastic leukemia enrolled in <scp>PETHEMA</scp> protocol... por Jordi Ribera, Mireia Morgades, Lurdes Zamora, Pau Montesinos, Inés Gómez‐Seguí, Marta Pratcorona, Josep Sarrà, Ramón Guàrdia, Josep Nomdedéu, Mar Tormo, Joaquín Martínez‐López, Jesús María Hernández‐Rivas, José González‐Campos, Pere Barba, Lourdes Escoda, Eulàlia Genescà, Françesc Solé, Fuensanta Millá, Evarist Feliú, Josep‐María Ribera

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status

    Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status por Josep‐María Ribera, Olga García, Carlos Grande, Jordi Esteve, Albert Oriol, Juan Bergua, José González‐Campos, Ferrán Vall-Llovera, Mar Tormo, Jesús María Hernández‐Rivas, Daniel Fernández-García, Salut Brunet, Natalia Alonso, Pere Barba, Pilar Miralles, Andreu Llorente, Pau Montesinos, M.-J. Moreno, José‐Ángel Hernández‐Rivas, Teresa Bernal

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: